(Q46584613)

23 December 2017

title

Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy (English)

1 reference

23 December 2017

1 reference

Jin-Ying Lu

1

1 reference

23 December 2017

Lee-Ming Chuang

2

1 reference

23 December 2017

Wei-Shiung Yang

3

1 reference

23 December 2017

Tong-Yuan Tai

4

1 reference

23 December 2017

Ming-Yang Lai

5

1 reference

23 December 2017

Pei-Jer Chen

6

1 reference

23 December 2017

Jia-Horng Kao

7

1 reference

23 December 2017

Cha-Ze Lee

8

1 reference

23 December 2017

Hsuan-Shu Lee

9

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

published in

Liver International

1 reference

23 December 2017

volume

25

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

752-759

1 reference

23 December 2017

Association of diabetes mellitus and chronic hepatitis C virus infection.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Host factors and failure of interferon-alpha treatment in hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Acute hepatitis induced by alpha-interferon, associated with viral clearance, in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.1007.X

10.1111/J.1478-3231.2005.1007.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017